Lusutrombopag

COMPOSITION:

Each film-coated tablet contains Lusutrombopag…………………………………………………..3mg.

INDICATIONS:

LuciLusu is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.

DOSAGE AND USE:

Begin LuciLusu dosing 8-14 days prior to a scheduled procedure.

Patients should undergo their procedure 2-8 days after the last dose.

Recommended Dosage: 3 mg orally once daily with or without food for 7 days.

STORAGE:

In a dry place and store at 20℃ to 25℃.

MANUFACTURED AND MARKETED BY:

LUCIUS PHARMACEUTICALS(LAO) CO., LTD

No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNINGS:

Keep medicine out of reach of Children. Do not administer LuciLusu during Pregnancy and Lactation.